Xuning Shen
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Immune cells in cancer
Papers in
-
- Circular RNAs in diseases 5
- RNA modifications and cancer 2
- Kruppel-like factors research 1
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 4
- Co-authors
- Wei Chen (3 shared papers)Xueli Bai (3 shared papers)Xuefeng Xia (2 shared papers)Tingbo Liang (2 shared papers)Tao Ma (1 shared paper)Guodong Xu (1 shared paper)Yi Zhu (7 shared papers)Zhiheng Chen (7 shared papers)
- Journals
- OncoTargets and Therapy (2 papers)Inflammation Research (1 paper)Liver International (1 paper)Journal of Neuroscience (1 paper)Cell Death and Disease (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xuning Shen
19 papers receiving 537 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 228
- Immunology 132
- Molecular Biology 321
- Developmental Neuroscience 14
- Oncology 92
Countries citing papers authored by Xuning Shen
This map shows the geographic impact of Xuning Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuning Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuning Shen more than expected).
Fields of papers citing papers by Xuning Shen
This network shows the impact of papers produced by Xuning Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuning Shen. The network helps show where Xuning Shen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xuning Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 160 | |
| 2 | 2020 | 74 | |
| 3 | miR-145 suppresses breast cancer cell migration by targeting FSCN-1 and inhibiting epithelial-mesenchymal transition. | 2016 | 54 |
| 4 | 2018 | 48 | |
| 5 | 2011 | 38 | |
| 6 | 2020 | 33 | |
| 7 | 2023 | 27 | |
| 8 | 2019 | 26 | |
| 9 | 2019 | 23 | |
| 10 | 2009 | 12 | |
| 11 | 2018 | 12 | |
| 12 | 2020 | 10 | |
| 13 | 2021 | 8 | |
| 14 | 2020 | 5 | |
| 15 | 2019 | 4 | |
| 16 | 2024 | 2 | |
| 17 | 2024 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2022 | 1 |
About Xuning Shen
Xuning Shen is a scholar working on Molecular Biology, Cancer Research, Surgery, Genetics and Immunology, having authored 19 papers that have together received 539 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (5 papers), MicroRNA in disease regulation (4 papers), Cytokine Signaling Pathways and Interactions (2 papers), Inflammatory Bowel Disease (2 papers), IL-33, ST2, and ILC Pathways (2 papers), RNA modifications and cancer (2 papers) and Kruppel-like factors research (1 paper). The work is most often cited by research in Cancer Research (228 citations), Immunology (132 citations), Molecular Biology (321 citations), Developmental Neuroscience (14 citations) and Oncology (92 citations). Xuning Shen has collaborated with scholars based in China and United States. Frequent co-authors include Wei Chen, Xueli Bai, Xuefeng Xia, Tingbo Liang, Tao Ma, Guodong Xu, Yi Zhu, Zhiheng Chen, Honggang Jiang and Jiayan Mao. Their work appears in journals such as OncoTargets and Therapy, Inflammation Research, Liver International, Journal of Neuroscience and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.